371 related articles for article (PubMed ID: 18680446)
21. Inhalation of ambroxol inhibits cigarette smoke-induced acute lung injury in a mouse model by inhibiting the Erk pathway.
Ge LT; Liu YN; Lin XX; Shen HJ; Jia YL; Dong XW; Sun Y; Xie QM
Int Immunopharmacol; 2016 Apr; 33():90-8. PubMed ID: 26881857
[TBL] [Abstract][Full Text] [Related]
22. Effect of twelve-months therapy with oral ambroxol in preventing exacerbations in patients with COPD. Double-blind, randomized, multicenter, placebo-controlled study (the AMETHIST Trial).
Malerba M; Ponticiello A; Radaeli A; Bensi G; Grassi V
Pulm Pharmacol Ther; 2004; 17(1):27-34. PubMed ID: 14643168
[TBL] [Abstract][Full Text] [Related]
23. [Use of mucolytic preparations (Mucosolvan) in selected diseases of the upper respiratory tract. Part II].
Szmeja Z; Golusiński W; Mielcarek-Kuchta D; Laczkowska-Przybylska J
Otolaryngol Pol; 1997; 51(5):480-6. PubMed ID: 9557050
[TBL] [Abstract][Full Text] [Related]
24. A controlled trial of ambroxol in chronic bronchitis.
Guyatt GH; Townsend M; Kazim F; Newhouse MT
Chest; 1987 Oct; 92(4):618-20. PubMed ID: 3308343
[TBL] [Abstract][Full Text] [Related]
25. Steroid/mucokinetic hybrid nanoporous microparticles for pulmonary drug delivery.
Tewes F; Paluch KJ; Tajber L; Gulati K; Kalantri D; Ehrhardt C; Healy AM
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):604-13. PubMed ID: 23563102
[TBL] [Abstract][Full Text] [Related]
26. [Efficacy and safety of acute bronchitis treatment in adults--a comparison of Bronchosol® syrup and synthetic preparations with ambroxol. Results of observational study].
Fal AM; Schönknecht K
Wiad Lek; 2015; 68(2):139-44. PubMed ID: 26181148
[TBL] [Abstract][Full Text] [Related]
27. Antiinflammatory properties of ambroxol.
Beeh KM; Beier J; Esperester A; Paul LD
Eur J Med Res; 2008 Dec; 13(12):557-62. PubMed ID: 19073395
[TBL] [Abstract][Full Text] [Related]
28. Ambroxol for neuropathic pain: hiding in plain sight?
Russo MA; Baron R; Dickenson AH; Kern KU; Santarelli DM
Pain; 2023 Jan; 164(1):3-13. PubMed ID: 35580314
[TBL] [Abstract][Full Text] [Related]
29. [Ambroxol].
Akkoca Yildiz O
Tuberk Toraks; 2006; 54 Suppl 1():3-14. PubMed ID: 17089236
[No Abstract] [Full Text] [Related]
30. Intraluminal inflammation in the airways of patients with chronic bronchitis after treatment with Ambroxol.
Lusuardi M; Capelli A; Salmona M; Tacconi MT; Cerutti CG; Donner CF
Monaldi Arch Chest Dis; 1995 Oct; 50(5):346-51. PubMed ID: 8541815
[TBL] [Abstract][Full Text] [Related]
31. A controlled multicenter pediatric study in the treatment of acute respiratory tract diseases with the aid of a new specific compound, erdosteine (IPSE, Italian Pediatric Study Erdosteine).
Titti G; Lizzio A; Termini C; Negri P; Fazzio S; Mancini C
Int J Clin Pharmacol Ther; 2000 Aug; 38(8):402-7. PubMed ID: 10984014
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of tetrodotoxin (TTX)-resistant and TTX-sensitive neuronal Na(+) channels by the secretolytic ambroxol.
Weiser T; Wilson N
Mol Pharmacol; 2002 Sep; 62(3):433-8. PubMed ID: 12181417
[TBL] [Abstract][Full Text] [Related]
33. [Effect of mucolytic therapy on the production of reactive oxygen species in the blood of patients with an exacerbation of chronic obstructive pulmonary disease].
Farkhutdinov UR; Farkhutdinov RR; Petriakov VV; Farkhutdinov ShU; Mirkhaĭdarov AM
Ter Arkh; 2010; 82(3):29-32. PubMed ID: 20564918
[TBL] [Abstract][Full Text] [Related]
34. [Effects of carbocisteine on airway inflammation and related events in SO2-exposed rats].
Ishibashi Y; Okamura T; Masumoto Y; Tachiiri T; Momo K
Nihon Kokyuki Gakkai Zasshi; 2001 Jan; 39(1):17-23. PubMed ID: 11296380
[TBL] [Abstract][Full Text] [Related]
35. [The new possibility for the treatment of acute cough].
Klyachkina IL
Vestn Otorinolaringol; 2015; 80(5):85-90. PubMed ID: 26525480
[TBL] [Abstract][Full Text] [Related]
36. [The effect of inhaled ambroxol treatment on clinical symptoms and chosen parameters of ventilation in patients with exacerbation of chronic obstructive pulmonary disease patients].
Jahnz-Rózyk K; Kucharczyk A; Chciałowski A; Płusa T
Pol Merkur Lekarski; 2001 Sep; 11(63):239-43. PubMed ID: 11761819
[TBL] [Abstract][Full Text] [Related]
37. Clinical efficacy of ambroxol in the treatment of bronchial stasis. Clinical trial in 120 patients at two different doses.
Germouty J; Jirou-Najou JL
Respiration; 1987; 51 Suppl 1():37-41. PubMed ID: 3299566
[TBL] [Abstract][Full Text] [Related]
38. Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy.
Gillissen A; Nowak D
Respir Med; 1998 Apr; 92(4):609-23. PubMed ID: 9659525
[TBL] [Abstract][Full Text] [Related]
39. Pharmacokinetics and safety of salbutamol/ambroxol fixed-dose combination granules in healthy Chinese subjects
.
Wang Y; Lu J; Li T; Zhao S; Yang W; Liu L; Shi X; Michael M; Ding L
Int J Clin Pharmacol Ther; 2018 Dec; 56(12):597-603. PubMed ID: 30232958
[TBL] [Abstract][Full Text] [Related]
40. Effect of early ambroxol treatment on lung functions in mechanically ventilated preterm newborns who subsequently developed a bronchopulmonary dysplasia (BPD).
Schmalisch G; Wauer RR; Böhme B
Respir Med; 2000 Apr; 94(4):378-84. PubMed ID: 10845438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
